{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:06:01Z","timestamp":1792530361486,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["S10OD023527"],"award-info":[{"award-number":["S10OD023527"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","award":["SCR_022039"],"award-info":[{"award-number":["SCR_022039"]}],"id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-2134535"],"award-info":[{"award-number":["CBET-2134535"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-2011924"],"award-info":[{"award-number":["DMR-2011924"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000104","name":"National Aeronautics and Space Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["S10OD023527"],"award-info":[{"award-number":["S10OD023527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AI161306"],"award-info":[{"award-number":["R21 AI161306"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127063","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T17:38:55Z","timestamp":1743615535000},"page":"127063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles"],"prefix":"10.1016","volume":"53","author":[{"given":"Sweta","family":"Karan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Opdensteinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Fernanda Affonso","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole F.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127063_bb0005","article-title":"Covid-19: four fifths of cases are asymptomatic, China figures indicate","volume":"369","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127063_bb0010","series-title":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship, Yokohama, Japan","author":"Mizumoto","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127063_bb0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009316","article-title":"Universal screening for SARS-CoV-2 in women admitted for delivery","author":"Sutton","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127063_bb0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127063_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmv.25688","article-title":"The 2019-new coronavirus epidemic: evidence for virus evolution","volume":"92","author":"Benvenuto","year":"2020","journal-title":"J Med Virol"},{"issue":"6483","key":"10.1016\/j.vaccine.2025.127063_bb0030","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127063_bb0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127063_bb0040","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/JVI.06566-11","article-title":"Self-assembly of viral capsid protein and RNA molecules of different sizes: requirement for a specific high protein\/RNA mass ratio","volume":"86","author":"Cadena-Nava","year":"2012","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127063_bb0045","doi-asserted-by":"crossref","first-page":"12271","DOI":"10.1128\/JVI.01695-12","article-title":"In vitro quantification of the relative packaging efficiencies of single-stranded RNA molecules by viral capsid protein","volume":"86","author":"Comas-Garcia","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2013.03.001","article-title":"Reconstituted plant viral capsids can release genes to mammalian cells","volume":"441","author":"Azizgolshani","year":"2013","journal-title":"Virology"},{"issue":"27","key":"10.1016\/j.vaccine.2025.127063_bb0055","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1021\/jp503050z","article-title":"Characterization of viral capsid protein self-assembly around short single-stranded RNA","volume":"118","author":"Comas-Garcia","year":"2014","journal-title":"J Phys Chem B"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/acs.accounts.5b00350","article-title":"Physical principles in the self-assembly of a simple spherical virus","volume":"49","author":"Garmann","year":"2016","journal-title":"Acc Chem Res"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127063_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215031","article-title":"Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles","volume":"14","author":"Biddlecome","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1487","article-title":"Plant viral and bacteriophage delivery of nucleic acid therapeutics","volume":"10","author":"Lam","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127063_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12033-014-9826-1","article-title":"In planta production of flock house virus transencapsidated RNA and its potential use as a vaccine","volume":"57","author":"Zhou","year":"2015","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2025.127063_bb0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.aivir.2018.06.003","article-title":"TMV particles: the journey from fundamental studies to bionanotechnology applications","volume":"102","author":"Lomonossoff","year":"2018","journal-title":"Adv Virus Res"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127063_bb0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127063_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01356-17","article-title":"Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent","volume":"8","author":"Shepardson","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2025.127063_bb0095","article-title":"Endosomal toll-like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus","author":"Albakri","year":"2019","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127063_bb0100","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.nano.2017.10.015","article-title":"Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7\/8 agonist","volume":"14","author":"Carignan","year":"2018","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127063_bb0105","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.1103312","article-title":"Innate immunity mediates follicular transport of particulate but not soluble protein antigen","volume":"188","author":"Link","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0110","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127063_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0042-6822(86)90194-7","article-title":"Packaging of recombinant RNA molecules into pseudovirus particles directed by the origin-of-assembly sequence from tobacco mosaic virus RNA","volume":"155","author":"Sleat","year":"1986","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127063_bb0120","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/nar\/17.2.815","article-title":"Direct recovery of in vitro transcripts in a protected form suitable for prolonged storage and shipment at ambient temperatures","volume":"17","author":"Jupin","year":"1989","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0022-2836(89)90006-5","article-title":"Assembly of hybrid RNAs with tobacco mosaic virus coat protein. Evidence for incorporation of disks in 5\u2032-elongation along the major RNA tail","volume":"209","author":"Turner","year":"1989","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0022-2836(88)90190-8","article-title":"The tobacco mosaic virus assembly origin RNA. Functional characteristics defined by directed mutagenesis","volume":"203","author":"Turner","year":"1988","journal-title":"J Mol Biol"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127063_bb0135","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1073\/pnas.91.19.9067","article-title":"Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli","volume":"91","author":"Hwang","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1099\/0022-1317-30-1-137","article-title":"Absence of poly (a) from the infective RNA of Nodamura virus","volume":"30","author":"Newman","year":"1976","journal-title":"J Gen Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127063_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200040","article-title":"Isolation of tobacco mosaic virus-binding peptides for biotechnology applications","volume":"23","author":"Chan","year":"2022","journal-title":"Chembiochem"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/acsbiomaterials.6b00769","article-title":"A bioengineered positive control for rapid detection of the Ebola virus by reverse transcription loop-mediated isothermal amplification (RT-LAMP)","volume":"3","author":"Lam","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127063_bb0155","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/bm2014558","article-title":"Mutant plant viruses with cell binding motifs provide differential adhesion strengths and morphologies","volume":"13","author":"Lee","year":"2012","journal-title":"Biomacromolecules"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2025.127063_bb0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0014-5793(03)00549-0","article-title":"Misfolded plant virus proteins: elicitors and targets of ubiquitylation","volume":"545","author":"Jockusch","year":"2003","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127063_bb0165","article-title":"Crystal structure of a four-layer aggregate of engineered TMV CP implies the importance of terminal residues for oligomer assembly","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0042-6822(66)90117-6","article-title":"Some factors affecting particle length distribution in tobacco mosaic virus preparations","volume":"30","author":"Francki","year":"1966","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0175","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2025.127063_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11095-021-03008-w","article-title":"Grand challenges in pharmaceutical research series: ridding the cold chain for biologics","volume":"38","author":"Yu","year":"2021","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.11613\/BM.2011.029","article-title":"Multiple comparison analysis testing in ANOVA","volume":"21","author":"McHugh","year":"2011","journal-title":"Biochem Med (Zagreb)"},{"issue":"36","key":"10.1016\/j.vaccine.2025.127063_bb0195","doi-asserted-by":"crossref","first-page":"14748","DOI":"10.1021\/jacs.1c06600","article-title":"Trivalent subunit vaccine candidates for COVID-19 and their delivery devices","volume":"143","author":"Ortega-Rivera","year":"2021","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127063_bb0200","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/acs.biomac.2c00112","article-title":"Injectable slow-release hydrogel formulation of a plant virus-based COVID-19 vaccine candidate","volume":"23","author":"Nkanga","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.vaccine.2025.127063_bb0205","first-page":"1","article-title":"COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response","author":"Affonso","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127063_bb0210","series-title":"Discoveries in Plant Biology","first-page":"105","article-title":"The Discovery of the Causal Agent of the Tobacco Mosaic Disease","author":"Zaitlin","year":"1898"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127063_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004529","article-title":"Rapid evolution of virus sequences in intrinsically disordered protein regions","volume":"10","author":"Gitlin","year":"2014","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127063_bb0220","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/jvi.66.4.2326-2334.1992","article-title":"Replication of nodamura virus after transfection of viral RNA into mammalian cells in culture","volume":"66","author":"Ball","year":"1992","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127063_bb0225","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.addr.2006.09.014","article-title":"Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging","volume":"58","author":"Manchester","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"5712","key":"10.1016\/j.vaccine.2025.127063_bb0230","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.307.5712.1028b","article-title":"As Gelsinger case ends, gene therapy suffers another blow","volume":"307","author":"Couzin","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127063_bb0235","first-page":"715","article-title":"Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo","volume":"2","author":"Kaiser","year":"2007","journal-title":"Int J Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.127063_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2007.04.003","article-title":"Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo","volume":"120","author":"Singh","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2025.127063_bb0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2013.10.035","article-title":"Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice","volume":"449","author":"Bruckman","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127063_bb0250","article-title":"Stealth filaments: polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X","author":"Lee","year":"2015","journal-title":"Acta Biomater"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0255","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/acsnano.9b07865","article-title":"Antibody response against cowpea mosaic viral nanoparticles improves in situ vaccine efficacy in ovarian Cancer","volume":"14","author":"Shukla","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.vaccine.2025.127063_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3233(03)01001-5","article-title":"Viral assembly using heterologous expression systems and cell extracts","volume":"64","author":"Schneemann","year":"2003","journal-title":"Adv Protein Chem"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2025.127063_bb0265","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1008040221630","article-title":"Comparison of manufacturing techniques for adenovirus production","volume":"30","author":"Iyer","year":"1999","journal-title":"Cytotechnology"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127063_bb0270","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.gt.3300454","article-title":"The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes","volume":"4","author":"Tang","year":"1997","journal-title":"Gene Ther"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127063_bb0275","doi-asserted-by":"crossref","first-page":"12744","DOI":"10.1073\/pnas.94.24.12744","article-title":"Gene therapy","volume":"94","author":"Kay","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127063_bb0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0005-2736(95)80018-B","article-title":"Complexes between cationic liposomes and DNA visualized by cryo-TEM","volume":"1235","author":"Gustafsson","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127063_bb0285","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<289::AID-JPS1>3.0.CO;2-N","article-title":"Physical stability of nonviral plasmid-based therapeutics","volume":"89","author":"Anchordoquy","year":"2000","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127063_bb0290","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41578-021-00399-5","article-title":"Integrating plant molecular farming and materials research for next-generation vaccines","volume":"7","author":"Chung","year":"2022","journal-title":"Nat Rev Mater"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127063_bb0295","doi-asserted-by":"crossref","first-page":"19948","DOI":"10.1038\/s41598-023-47086-9","article-title":"Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate","volume":"13","author":"Tanelus","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127063_bb0300","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/13543784.16.7.927","article-title":"Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use","volume":"16","author":"Safdar","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127063_bb0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.4253","article-title":"A chikungunya fever vaccine utilizing an insect-specific virus platform","volume":"23","author":"Erasmus","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127063_bb0310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/apb.2022.0037","article-title":"Viral replicon systems and their biosafety aspects","volume":"28","author":"van der Meulen","year":"2023","journal-title":"Appl Biosaf"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127063_bb0315","article-title":"Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice","volume":"9","author":"Maharjan","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.127063_bb0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jviromet.2010.02.026","article-title":"In vitro assembly of tobacco mosaic virus coat protein variants derived from fission yeast expression clones or plants","volume":"166","author":"Mueller","year":"2010","journal-title":"J Virol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25003603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:09:07Z","timestamp":1778040547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25003603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"alternative-id":["S0264410X25003603"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127063"}}